首页医院概况医疗服务科室导航专科专家医疗技术新闻中心人事招聘
官方微信
您的位置:首页 > 新闻中心 > 媒体聚焦

《新华社》Xinhua Headlines: China's Guangdong expands nucleic acid testing to include everyone in need

2020-05-15 11:26 编辑:管理员 阅读次数:408

-- South China's Guangdong Province has been endeavoring to ensure anyone who is required to take a test or wants one can get tested for COVID-19 while accelerating its production resumption.

-- By May 11, the economic powerhouse had completed nearly 5.54 million nucleic acid tests for people with high risks of infection and its daily capacity of nucleic acid tests had reached 230,000.

by Xinhua writers Xiao Sisi, Li Laifang and Hong Zehua

GUANGZHOU, May 15 (Xinhua) -- South China's Guangdong Province had carried out 10.41 million nucleic acid tests as of Monday, covering 6.64 million people as the populous province has been on full alert against COVID-19.

The economic powerhouse has been endeavoring to ensure anyone who is required to take a test or wants one can get tested for COVID-19, amid efforts of work and production resumption.

A staff member looks at the label on a sample at a lab in Guangzhou, south China's Guangdong Province, Feb. 1, 2020. (Xinhua)

LARGE-SCALE TESTING

Every day, there are ambulances and logistics vehicles with samples for COVID-19 tests rushing to Guangzhou KingMed Diagnostics Group Co., Ltd., a leader of the independent clinical lab industry in China. The company undertakes screening tests assigned by hospitals and the government.

"Since Jan. 24, the lab at our Guangzhou headquarters has continuously conducted nucleic acid tests for over 100 days," said Cheng Yating, assistant president of KingMed and general manager of its lab management center. The group's Guangzhou lab had completed tests of more than 2 million samples by Tuesday, with a daily peak of 96,000.

As China's COVID-19 response has entered the phase of regular epidemic prevention and control after winning a decisive outcome in fighting the epidemic, the country is still taking strict measures to prevent a rebound of the coronavirus.

On April 22, a meeting of the leading group of China's COVID-19 epidemic response urged efforts to enhance the testing capability and carry out large-scale nucleic acid and antibody tests, to contribute to implementing targeted prevention and control, protecting people's health, ensuring the reasonable flow of people and comprehensively resuming work and production.

Nucleic acid testing is the prime standard to confirm COVID-19 infections, and the early diagnosis of confirmed and asymptomatic cases is conducive to blocking the spread of the virus, said an official with the Guangdong headquarters for COVID-19 prevention and control.

Staff members do nucleic acid tests at a lab in Guangzhou, south China's Guangdong Province, Feb. 13, 2020. (Xinhua)

By March, 99.2 percent of major enterprises in Guangdong had resumed operations. In April, the overall economic operations in Guangdong had reached the level of the same period last year, according to the taxation authority.

"For people who come from abroad or return to work, Guangdong has carried out mass screening via nucleic acid tests for key groups. We have done it at an early date and effectively, which plays a key role in epidemic prevention and control," said Wu Jie, with the Guangdong Provincial Center for Disease Control and Prevention.

ENHANCING TESTING CAPABILITY

By the end of Thursday, Guangdong had reported a total of 1,395 locally transmitted confirmed COVID-19 cases and 194 imported cases, with two patients still in the hospital.

To meet the needs of testing, the number of approved nucleic acid testing institutions -- hospitals, disease control, and prevention centers, and private companies -- has risen from 135 in the early phase to 251 in Guangdong. The province's daily capacity of nucleic acid tests has reached 230,000.

A staff member puts samples into a centrifuge at a lab in Guangzhou, south China's Guangdong Province, Feb. 13, 2020. (Xinhua)

Guangdong health authorities have also strengthened administration to ensure the quality of testing by third-party institutions and provided technical guidelines for them.

Businessman Ahamed Al-Yafie received nucleic acid testing near his neighborhood after returning to Guangzhou from his vacation in Malaysia three months ago.

"It is very impressive that COVID-19 has been put under control in China while the country has a population of 1.4 billion," said Al-Yafie.

Authorities in Wuhan, capital of central China's Hubei Province, said Thursday it will expand the scope of nucleic acid testing to strengthen the control of asymptomatic cases after it has already completed over 3 million nucleic acid tests. 

Xu Hongyi, Hu Nayun, and Ma Xiaoran also contributed to the reporting. (Video reporters: Xiao Sisi, Hu Nayun, Xu Hongyi, Hong Zehua; Video editor: Zheng Xin)

热点新闻
健康大讲堂
动态|广州市一医院开展2020年“中秋、国庆”节前安全大检查
再创新高!广州市第一人民医院喜获2020年度国家自然科学基金立项22项
感动!时隔200多天,援鄂医生回武汉与80岁父亲团聚
广州市第一人民医院生殖中心辅助生殖技术再次全票通过现场校验
致敬时代楷模—广州市第一人民医院代表广东支援雷神山医疗队讲述樱花树下的故事…
国家食药局就骨科3D打印技术在广州市第一人民医院(华南理工大学附属第二医院)开展调研座谈
迎新!2020届新护士们乘风破浪吧!
广州市一医院成功举办2020血糖护理管理挑战赛
动态|第三届粤港澳大湾区男性性功能障碍培训班成功举办
数据说话 时间说话:广州市第一人民医院六年连上“顶级医院百强榜”
帮扶 | 西藏波密34周早产儿命悬一线,第七批援藏医疗队紧急救治
广州市第一人民医院联合首彩爱心基金启动扶贫救心活动
载誉而归!广州市第一人民医院最美医师们揽奖多项
向医师致敬!广州市第一人民医院举办医师节主题活动
帮扶 | 西藏波密有儿科了!让雪域高原的孩子看病不离乡
聚焦护理教育,广州市第一人民医院举办2020年临床护理教学师资培训班
动态|广州市一医院开展2020年住院医师规范化岗前培训
求学科研路 矢志追梦人!广州市一医院成功举办2020年护理创新与科研专项培训
动态 | “小儿肾脏病与免疫性疾病诊治进展学习班”在我院成功举办